GlassScriptPhysician profile
Marlena Klein
NPI 1457871063
$2,039.32
in general payments reported to CMS, 2019-2025
8 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $277 · 2022: $380 · 2023: $454 · 2024: $300 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,148.23 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $540.67 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Genentech USA, INC. | $160.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $100.00 | 2020 | |
| Astellas Pharma US INC | $38.66 | 2025 | Veozah |
| Exact Sciences Corporation | $20.09 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.84 | 2024 | Keytruda |
| Agile Therapeutics, INC. | $14.83 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlena Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.